GLP-1 Market
完整報告名稱與涵蓋範圍
GLP-1 Market Size, Share & Trends Analysis Distribution by Type of Molecule (Biologics and Small Molecules), Active Compound Used (Dulaglutide, Liraglutide, Orforglipron, Retatrutide, Semaglutide, Survodutide, Tirzepatide and Other Active Compounds), Type of GLP-1 Agonist Drugs, Type of Agonist, Target indication, Route of Administration and Segment Forecasts, 2025-2034
報告摘要
In 2024, the GLP-1 Market worldwide was assessed at USD 50.0 Billion. Analysts project it will expand to USD 141.9 Billion by 2034, at a CAGR of 11.1% spanning 2025 to 2034.
At its core, GLP-1 pertains to The glucagon-like peptide-1 receptor (GLP1R) represents a crucial target in treating type 2 diabetes and obesity, given its pronounced role in regulating blood sugar levels and appetite. Stakeholders across the healthcare landscape are growingly turning to these solutions to meet contemporary demands.
Several factors contribute to this trajectory, including heightened call for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region projected to deliver the strongest growth trajectory through the forecast period, fueled by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global 3D Printed Satellite Market Snapshot
Chapter 4. Global 3D Printed Satellite Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type of Molecule Estimates & Trend Analysis
5.1. by Type of Molecule & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Type of Molecule:
5.2.1. Biologics
5.2.2. Small Molecules
Chapter 6. Market Segmentation 2: by Active Compound Used Estimates & Trend Analysis
6.1. by Active Compound Used & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Active Compound Used:
6.2.1. Dulaglutide
6.2.2. Liraglutide
6.2.3. Orforglipron
6.2.4. Retatrutide
6.2.5. Semaglutide
6.2.6. Survodutide
6.2.7. Tirzepatide
6.2.8. Other Active Compounds
Chapter 7. Market Segmentation 3: by Type of GLP-1 Agonist Drugs Estimates & Trend Analysis
7.1. by Type of GLP-1 Agonist Drugs & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Type of GLP-1 Agonist Drugs:
7.2.1. Long-acting GLP-1 Agonist
7.2.2. Short-acting GLP-1 Agonist
Chapter 8. Market Segmentation 4: by Type of Agonist Estimates & Trend Analysis
8.1. by Type of Agonist & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Type of Agonist:
8.2.1. Single agonist
8.2.2. Dual agonist
8.2.3. Tri-agonist
Chapter 9. Market Segmentation 5: by Route of Administration Estimates & Trend Analysis
9.1. by Route of Administration & Market Share, 2024 & 2034
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Route of Administration:
9.2.1. Oral
9.2.2. Parenteral
Chapter 10. Market Segmentation 6: by Target Indication Estimates & Trend Analysis
10.1. by Target Indication & Market Share, 2024 & 2034
10.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Target Indication:
10.2.1. Alzheimer's Disease
10.2.2. Non-Alcoholic Steatohepatitis
10.2.3. Obesity
10.2.4. Sleep Apnea
10.2.5. Type 2 Diabetes
Chapter 11. 3D Printed Satellite Market Segmentation 7: Regional Estimates & Trend Analysis
11.1. North America
11.1.1. North America 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Type of Molecule, 2021-2034
11.1.2. North America 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Active Compound Used, 2021-2034
11.1.3. North America 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Type of GLP-1 Agonist Drugs, 2021-2034
11.1.4. North America 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Type of Agonist, 2021-2034
11.1.5. North America 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
11.1.6. North America 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Target Indication, 2021-2034
11.1.7. North America 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
11.2. Europe
11.2.1. Europe 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Type of Molecule, 2021-2034
11.2.2. Europe 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Active Compound Used, 2021-2034
11.2.3. Europe 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Type of GLP-1 Agonist Drugs, 2021-2034
11.2.4. Europe 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Type of Agonist, 2021-2034
11.2.5. Europe 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
11.2.6. Europe 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Target Indication, 2021-2034
11.2.7. Europe 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
11.3. Asia Pacific
11.3.1. Asia Pacific 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Type of Molecule, 2021-2034
11.3.2. Asia Pacific 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Active Compound Used, 2021-2034
11.3.3. Asia-Pacific 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Type of GLP-1 Agonist Drugs, 2021-2034
11.3.4. Asia-Pacific 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Type of Agonist, 2021-2034
11.3.5. Asia Pacific 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
11.3.6. Asia Pacific 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Target Indication, 2021-2034
11.3.7. Asia Pacific 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
11.4. Latin America
11.4.1. Latin America 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Type of Molecule, 2021-2034
11.4.2. Latin America 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Active Compound Used, 2021-2034
11.4.3. Latin America 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Type of GLP-1 Agonist Drugs, 2021-2034
11.4.4. Latin America 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Type of Agonist, 2021-2034
11.4.5. Latin America 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
11.4.6. Latin America 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Target Indication, 2021-2034
11.4.7. Latin America 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
11.5. Middle East & Africa
11.5.1. Middle East & Africa 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Type of Molecule, 2021-2034
11.5.2. Middle East & Africa 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Active Compound Used, 2021-2034
11.5.3. Middle East & Africa 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Type of GLP-1 Agonist Drugs, 2021-2034
11.5.4. Middle East & Africa 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Type of Agonist, 2021-2034
11.5.5. Middle East & Africa 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
11.5.6. Middle East & Africa 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by Target Indication, 2021-2034
11.5.7. Middle East & Africa 3D Printed Satellite Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles
12.2.1. AstraZeneca
12.2.2. Biolingus
12.2.3. Boehringer Ingelheim
12.2.4. D&D Pharmatech
12.2.5. Eli Lilly
12.2.6. Gmax Biopharm
12.2.7. Hanmi Pharmaceutical
12.2.8. Innogen
12.2.9. Novo Nordisk
12.2.10. PegBio
12.2.11. Pfizer
12.2.12. QL Biopharma
12.2.13. Roche
12.2.14. Sanofi
12.2.15. Sciwind Biosciences
12.2.16. Tonghua Dongbao Pharmaceutical
12.2.17. Viking Therapeutics
12.2.18. Vivani
12.2.19. vTv Therapeutic
12.2.20. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們